Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

Pharmacological characterization of human incretin receptor missense variants.

Fortin JP, Schroeder JC, Zhu Y, Beinborn M, Kopin AS.

J Pharmacol Exp Ther. 2010 Jan;332(1):274-80. doi: 10.1124/jpet.109.160531. Epub 2009 Oct 19.

2.

The GIP receptor displays higher basal activity than the GLP-1 receptor but does not recruit GRK2 or arrestin3 effectively.

Al-Sabah S, Al-Fulaij M, Shaaban G, Ahmed HA, Mann RJ, Donnelly D, Bünemann M, Krasel C.

PLoS One. 2014 Sep 5;9(9):e106890. doi: 10.1371/journal.pone.0106890. eCollection 2014.

3.

Discovery of dual-action membrane-anchored modulators of incretin receptors.

Fortin JP, Chinnapen D, Beinborn M, Lencer W, Kopin AS.

PLoS One. 2011;6(9):e24693. doi: 10.1371/journal.pone.0024693. Epub 2011 Sep 14.

4.

GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.

Hansotia T, Drucker DJ.

Regul Pept. 2005 Jun 15;128(2):125-34. Review.

PMID:
15780432
5.

Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice.

Maida A, Hansotia T, Longuet C, Seino Y, Drucker DJ.

Gastroenterology. 2009 Dec;137(6):2146-57. doi: 10.1053/j.gastro.2009.09.004. Epub 2009 Sep 17.

PMID:
19766644
6.
7.

Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.

Gelling RW, Wheeler MB, Xue J, Gyomorey S, Nian C, Pederson RA, McIntosh CH.

Endocrinology. 1997 Jun;138(6):2640-3.

PMID:
9165060
8.

Selectivity of peptide ligands for the human incretin receptors expressed in HEK-293 cells.

Al-Sabah S, Al-Fulaij M, Ahmed HA.

Eur J Pharmacol. 2014 Oct 15;741:311-5. doi: 10.1016/j.ejphar.2014.08.019. Epub 2014 Aug 30.

PMID:
25179575
9.

Novel extrapancreatic effects of incretin.

Yamada Y, Tsukiyama K, Sato T, Shimizu T, Fujita H, Narita T.

J Diabetes Investig. 2016 Apr;7 Suppl 1:76-9. doi: 10.1111/jdi.12495. Epub 2016 Mar 31. Review.

10.

Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function.

Shu L, Matveyenko AV, Kerr-Conte J, Cho JH, McIntosh CH, Maedler K.

Hum Mol Genet. 2009 Jul 1;18(13):2388-99. doi: 10.1093/hmg/ddp178. Epub 2009 Apr 21. Erratum in: Hum Mol Genet. 2015 May 15;24(10):3004.

11.

Umami receptor activation increases duodenal bicarbonate secretion via glucagon-like peptide-2 release in rats.

Wang JH, Inoue T, Higashiyama M, Guth PH, Engel E, Kaunitz JD, Akiba Y.

J Pharmacol Exp Ther. 2011 Nov;339(2):464-73. doi: 10.1124/jpet.111.184788. Epub 2011 Aug 16.

12.

Incretin receptor null mice reveal key role of GLP-1 but not GIP in pancreatic beta cell adaptation to pregnancy.

Moffett RC, Vasu S, Thorens B, Drucker DJ, Flatt PR.

PLoS One. 2014 Jun 13;9(6):e96863. doi: 10.1371/journal.pone.0096863. eCollection 2014.

13.

Tyr1 and Ile7 of glucose-dependent insulinotropic polypeptide (GIP) confer differential ligand selectivity toward GIP and glucagon-like peptide-1 receptors.

Moon MJ, Kim HY, Kim SG, Park J, Choi DS, Hwang JI, Seong JY.

Mol Cells. 2010 Aug;30(2):149-54. doi: 10.1007/s10059-010-0100-5. Epub 2010 Aug 19.

14.

Effects of chronic exposure of clonal β-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1.

Pathak V, Vasu S, Flatt PR, Irwin N.

Diabetes Obes Metab. 2014 Apr;16(4):357-65. doi: 10.1111/dom.12227. Epub 2013 Nov 20.

PMID:
24164718
15.

Expression of glucagon-like peptide-1 receptor and glucose‑dependent insulinotropic polypeptide receptor is regulated by the glucose concentration in mouse osteoblastic MC3T3-E1 cells.

Aoyama E, Watari I, Podyma-Inoue KA, Yanagishita M, Ono T.

Int J Mol Med. 2014 Aug;34(2):475-82. doi: 10.3892/ijmm.2014.1787. Epub 2014 May 27.

PMID:
24866833
16.

Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways.

Friedrichsen BN, Neubauer N, Lee YC, Gram VK, Blume N, Petersen JS, Nielsen JH, Møldrup A.

J Endocrinol. 2006 Mar;188(3):481-92.

17.

Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells.

Moens K, Heimberg H, Flamez D, Huypens P, Quartier E, Ling Z, Pipeleers D, Gremlich S, Thorens B, Schuit F.

Diabetes. 1996 Feb;45(2):257-61.

PMID:
8549871
18.

Receptors and effects of gut hormones in three osteoblastic cell lines.

Pacheco-Pantoja EL, Ranganath LR, Gallagher JA, Wilson PJ, Fraser WD.

BMC Physiol. 2011 Jul 29;11:12. doi: 10.1186/1472-6793-11-12.

19.

Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation.

Yabe D, Seino Y.

Prog Biophys Mol Biol. 2011 Nov;107(2):248-56. doi: 10.1016/j.pbiomolbio.2011.07.010. Epub 2011 Jul 28. Review.

PMID:
21820006
20.

New physiological effects of the incretin hormones GLP-1 and GIP.

Asmar M.

Dan Med Bull. 2011 Feb;58(2):B4248. Review.

PMID:
21299928

Supplemental Content

Support Center